joseph kyana

Dr. joseph kyana

Université de Kisangani, Kisangani, Tshopo, Democratic Republic of the Congo
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MLMiryam M. Luzala
Miryam M. Luzala
CMClaude Josué Muanga
Claude Josué Muanga
JKjoseph kyana
joseph kyana
JSJustin Bazibuhe Safari
Justin Bazibuhe Safari
EZEunice N. Zola
Eunice N. Zola
PMPatrick B. Memvanga
Patrick B. Memvanga
Metallic nanoparticles (MNPs) produced by green synthesis using plant extracts have attracted huge interest in the scientific community due to their excellent antibacterial, antifungal and antibiofilm activities. To evaluate these pharmacological properties, several methods or protocols have been successfully developed and implemented. Although these protocols were mostly inspired by the guidelines from national and international regulatory bodies, they suffer from a glaring absence of standardization of the experimental conditions. This situation leads to a lack of reproducibility and comparability of data from different study settings. To minimize these problems, guidelines for the antimicrobial and antibiofilm evaluation of MNPs should be developed by specialists in the field. Being aware of the immensity of the workload and the efforts required to achieve this, we set out to undertake a meticulous literature review of different experimental protocols and laboratory conditions used for the antimicrobial and antibiofilm evaluation of MNPs that could be used as a basis for future guidelines. This review also brings together all the discrepancies resulting from the different experimental designs and emphasizes their impact on the biological activities as well as their interpretation. Finally, the paper proposes a general overview that requires extensive experimental investigations to set the stage for the future development of effective antimicrobial MNPs using green synthesis.

7 September 2025 in Processes
Verified
Journal Article
Open access
PDF file
Aiste BalciunaitieneAiste Balciunaitiene
Aiste Balciunaitiene
Hijab ZehraHijab Zehra
Hijab Zehra
MLMindaugas Liaudanskas
Mindaugas Liaudanskas
Jonas ViškelisJonas Viškelis
Jonas Viškelis
Sonata TrumbeckaiteSonata Trumbeckaite
Sonata Trumbeckaite
Pranas ViskelisPranas Viskelis
Pranas Viskelis
Silver nanoparticle (AgNP) biosynthesis using propolis extracts as capping and reducing agents presents multiple opportunities for solving many biological challenges. This study demonstrates a sustainable, low toxicity, and high production cost phytochemical synthesis of AgNPs using propolis extracts and microwaves. Biosynthesized with propolis, AgNPs are analyzed by various methods: phytochemical, physicochemical, and morphological, such as TEM. The determined antimicrobial and antioxidant activity of propolis extracts is compared with the activity of green synthesized AgNPs with propolis. The green synthesized AgNPs are spherically shaped with an average size ranging from 6 to 40 nm. The biosynthesized AgNPs demonstrate potential antibacterial activity on tested microorganism strains two folds higher than pure propolis extracts.